JPH06273702A - Contact lens having drug supplying capacity - Google Patents

Contact lens having drug supplying capacity

Info

Publication number
JPH06273702A
JPH06273702A JP5096419A JP9641993A JPH06273702A JP H06273702 A JPH06273702 A JP H06273702A JP 5096419 A JP5096419 A JP 5096419A JP 9641993 A JP9641993 A JP 9641993A JP H06273702 A JPH06273702 A JP H06273702A
Authority
JP
Japan
Prior art keywords
drug
contact lens
little
contact lenses
contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5096419A
Other languages
Japanese (ja)
Inventor
Chiaki Sano
千明 佐野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP5096419A priority Critical patent/JPH06273702A/en
Publication of JPH06273702A publication Critical patent/JPH06273702A/en
Pending legal-status Critical Current

Links

Landscapes

  • Eyeglasses (AREA)

Abstract

PURPOSE:To solve the pains of a patient who is forced to frequently drop a drug in his eyes and vorgetting applying the drug by inserting the drug worked into a sheet form between two sheets of hydrous soft contact lenses. CONSTITUTION:The drug 3 is eluted little by little into the moisture (including tear liquid) in the contact lens by forming the contact lens into a structure of fixing the drug between the hydrous soft contact lenses 1, 2 thereby the drug is sufficiently supplied over a long period of time. Namely, the direct contact of the drug 3 with the fine tissues, such as cornea, does not arise and moreover, the elution of the drug into the moisture is utilized and, therefore, the safe and sufficient supply of the drug over a long period of time is possible. For example, a paper piece in which fluorescein (fluorescent dye) is experimentally incorporated is inserted between two sheets of the existing highly hydrous soft contact lenses. The dyestuff is eluted little by little, is penetrated into the blank material of the contact lensrd and is successively spread into the conjunctival sac if the patient wears such contact lenses.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】この発明は、含水性ソフトコンタ
クトレンズの構造内部に薬物を固定することにより、連
続的な薬物供給能力をもったコンタクトレンズに関する
ものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a contact lens having a continuous drug supplying ability by fixing a drug inside the structure of a hydrous soft contact lens.

【0002】[0002]

【従来の技術】従来、眼局所への薬物供給は、点眼によ
って行われていたが、薬物の供給濃度が時間と共に低下
して、十分かつ連続的な薬物供給ができなかった。
2. Description of the Related Art Conventionally, drug delivery to the ocular local area has been carried out by instillation, but the drug delivery concentration decreased with time, and sufficient and continuous drug delivery was not possible.

【0003】[0003]

【発明が解決しようとする課題】本発明は、その欠点を
のぞいて、もっと長時間にわたって、また連続的な薬物
供給能力をもつシステムの開発を課題とした。
With the exception of its drawbacks, the present invention has aimed at the development of a system having a drug supplying ability for a longer period of time and continuously.

【0004】[0004]

【課題を解決するための手段】薬剤を含水性コンタクト
レンズの内部に固定する構造をつくることによって、薬
剤が少しずつコンタクトレンズ内の水分(涙液も含む)
に溶けだし、長時間にわたって十分な薬物供給をさせる
ことを可能にしようとした。
[Means for Solving the Problems] By forming a structure for fixing a drug inside a hydrous contact lens, the drug gradually contains water (including tears) in the contact lens.
It tried to be able to dissolve in and to supply a sufficient drug for a long time.

【0005】[0005]

【作用】本発明は、以上のような構成であるから 薬物
が直接 角膜や結膜といった繊細な組織に接触すること
がなく、しかも薬物が水分に溶けだすことを利用してい
るため、安全に長時間、十分な薬物供給ができる。
[Advantages] Since the present invention has the above-mentioned constitution, the drug does not come into direct contact with delicate tissues such as the cornea and the conjunctiva, and moreover, the drug is dissolved in water, so that the drug can be safely and long-lived. Sufficient drug can be supplied for a long time.

【0006】[0006]

【実施例】実験的にフルオレセイン(蛍光色素)が含ま
れている紙片を、既成の高含水のソフトコンタクトレン
ズ2枚にはさみこみ、発明者が装用してみた。その結
果、色素は少しずつ溶け出し、コンタクトレンズ素材に
浸透し、結膜嚢内へと広がっていった。薬物の量、固形
法を変えることによって、薬物の結膜嚢内濃度および供
給時間はコントロールできると思われた。
EXAMPLE A piece of paper experimentally containing fluorescein (fluorescent dye) was sandwiched between two existing soft contact lenses with high water content, and the inventor tried to wear them. As a result, the pigment gradually melted, penetrated into the contact lens material, and spread into the conjunctival sac. By changing the amount of the drug and the solid method, the concentration of the drug in the conjunctival sac and the delivery time could be controlled.

【0007】[0007]

【発明の効果】この発明によって薬物の頻回点眼を強い
られていた患者の苦痛や、薬物のつけ忘れを解決するこ
とが可能である。また、角膜疾患の角膜保護の目的でソ
フトコンタクトレンズが使用される場合には、特に有効
な薬物供給システムになりうる。
According to the present invention, it is possible to solve the pain of a patient who has been forced to instill a drug frequently and forget to put the drug on. Moreover, when a soft contact lens is used for the purpose of corneal protection of corneal diseases, it can be a particularly effective drug supply system.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明平面図FIG. 1 is a plan view of the present invention.

【符号の説明】[Explanation of symbols]

(1)はコンタクトレンズその1 (2)はコンタクトレンズその2 (3)は薬物シート (1) is a contact lens 1 (2) is a contact lens 2 (3) is a drug sheet

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】2枚の含水性ソフトコンタクトレンズの間
に、シート状に加工された薬物をはさみこんだ 薬物供
給能力をもったコンタクトレンズ。
1. A contact lens having a drug supplying ability, which comprises a sheet-shaped drug sandwiched between two hydrous soft contact lenses.
【請求項2】2枚の含水性ソフトコンタクトレンズの代
わりに、薬物をはさみこめるような間隙をもった含水性
コンタクトレンズを使った請求項1の薬物供給能力をも
ったコンタクトレンズ。
2. A contact lens having a drug-supplying ability according to claim 1, wherein a hydrous contact lens having a space for sandwiching a drug is used in place of the two hydrous soft contact lenses.
【請求項3】薬物をはさみこむ代わりに、薬物をコンタ
クトレンズの素材に接着させた請求項1の薬物供給能力
をもったコンタクトレンズ。
3. A contact lens having the drug supply ability according to claim 1, wherein the drug is adhered to the material of the contact lens instead of sandwiching the drug.
JP5096419A 1993-03-18 1993-03-18 Contact lens having drug supplying capacity Pending JPH06273702A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5096419A JPH06273702A (en) 1993-03-18 1993-03-18 Contact lens having drug supplying capacity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5096419A JPH06273702A (en) 1993-03-18 1993-03-18 Contact lens having drug supplying capacity

Publications (1)

Publication Number Publication Date
JPH06273702A true JPH06273702A (en) 1994-09-30

Family

ID=14164464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5096419A Pending JPH06273702A (en) 1993-03-18 1993-03-18 Contact lens having drug supplying capacity

Country Status (1)

Country Link
JP (1) JPH06273702A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882996A2 (en) * 1997-06-05 1998-12-09 Menicon Co., Ltd. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
JP2007503265A (en) * 2003-08-26 2007-02-22 ヴィスタ サイエンティフィック エルエルシー Ophthalmic drug supply device
US9102105B2 (en) 2011-09-13 2015-08-11 Vista Scientific Llc Method for forming an ocular drug delivery device
JP2019144580A (en) * 2018-02-16 2019-08-29 真一 芦田 Medicine, supplement, optical device, correction tool for eye, magnetic material and contact lens
JP2019179095A (en) * 2018-03-30 2019-10-17 真一 芦田 Mounted object for eye, appliance for eye and holding body
JP2019179094A (en) * 2018-03-30 2019-10-17 真一 芦田 Attachment object for eye and medicine supply attachment object for eye
JP2019204035A (en) * 2018-05-25 2019-11-28 真一 芦田 Attachment to eye

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882996A2 (en) * 1997-06-05 1998-12-09 Menicon Co., Ltd. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
EP0882996A3 (en) * 1997-06-05 2000-04-12 Menicon Co., Ltd. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
JP2007503265A (en) * 2003-08-26 2007-02-22 ヴィスタ サイエンティフィック エルエルシー Ophthalmic drug supply device
JP2011156380A (en) * 2003-08-26 2011-08-18 Vista Scientific Llc Ocular drug delivery device
JP4869930B2 (en) * 2003-08-26 2012-02-08 ヴィスタ サイエンティフィック エルエルシー Ophthalmic drug supply device
US8167855B2 (en) 2003-08-26 2012-05-01 Vista Scientific Llc Ocular drug delivery device
US8287504B2 (en) 2003-08-26 2012-10-16 Vista Scientific Llc Ocular drug delivery device
US8679078B2 (en) 2003-08-26 2014-03-25 Vista Scientific Llc Ocular drug delivery device
US9102105B2 (en) 2011-09-13 2015-08-11 Vista Scientific Llc Method for forming an ocular drug delivery device
JP2019144580A (en) * 2018-02-16 2019-08-29 真一 芦田 Medicine, supplement, optical device, correction tool for eye, magnetic material and contact lens
JP2019179095A (en) * 2018-03-30 2019-10-17 真一 芦田 Mounted object for eye, appliance for eye and holding body
JP2019179094A (en) * 2018-03-30 2019-10-17 真一 芦田 Attachment object for eye and medicine supply attachment object for eye
JP2019204035A (en) * 2018-05-25 2019-11-28 真一 芦田 Attachment to eye

Similar Documents

Publication Publication Date Title
US4484922A (en) Occular device
EP1178779B1 (en) Ophthalmic insert and method for sustained release of medication to the eye
EP2648663B1 (en) Device for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus
US4908024A (en) Ocular self-treatment apparatus and method
US5627611A (en) Artificial tears
DE69527799D1 (en) MEDICINES FOR INCREASING CHAMBER WATER OUTFLOW IN GLAUCOMA TREATMENT
DK0550791T3 (en) Device for restoring the natural internal pressure of the eye
Hill et al. Oxygen deprivation of the cornea by contact lenses and lid closure
JP2007167358A (en) Intraocular drug administration appliance
JPH06273702A (en) Contact lens having drug supplying capacity
US5569224A (en) Eyedrop applicator
DK0403360T3 (en) Use of phenylethanolamines for the preparation of a drug for eye disorders
PT1021184E (en) UTILIZATION OF FLUNARIZIN FOR THE TOPICAL TREATMENT OF EYE HYPERTENSION
CN209808717U (en) Pupil shrinking device
Kirk et al. Minimizing corneal endothelial damage due to intraocular lens contact.
Duffey et al. Calcium deposition in a corneal graft
JP2673537B2 (en) Ocular treatment substance self-administration device
Holland Fluorescein staining of the cornea
Ansari Ocular injury with xylene-a report of two cases
Goldberg Corneal lenses before RGP, or those were the good (?) old days
RU10550U1 (en) OPHTHALMIC TREATMENT NOZZLE
Baerveldt Ophthalmology: Current Approach to Intractable Glaucoma
RU2017474C1 (en) Insert for treatment of chemical burn of eyes
RU99100578A (en) METHOD FOR TREATING EYE DISEASES
SU1727827A1 (en) Method for treatment of open-angle glaucoma